Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson’s Disease: A Pilot Study

Figure 3

Responder rates in patients (FAS). The responder rates for each outcome measure: PDSS-2, total score <18; EMO, patient improved at least 1 comparing to his/her baseline condition; CGI-I, clinician rated of any improvement (1 = very much better, 2 = much better, or 3 = a little better); PGI-I, patient rated of any improvement (1 = very much better, 2 = much better, or 3 = a little better). CGI-I, Clinical Global Impression of Improvement; CI, confidence interval; EMO, Early Morning Off; FAS, full analysis set; IR, immediate release; PDSS-2, Parkinson’s Disease Sleep Scale-2; PGI-I, Patient Global Impression of Improvement; SR, sustained release.